Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-25 @ 2:41 PM
NCT ID:
NCT00109850
Group ID:
EG000
Title:
Cetuximab+Cisplatin+Irinotecan Followed by RT in Cycle 3
Description:
Patients received four 21-day cycles of cetuximab 400 mg/m\^2 (day 1, cycle 1), cetuximab 250 mg/m\^2 (day 8, 15, cycle 1, then days 1, 8 and 15 for subsequent cycles), cisplatin 30 mg/m\^2 (days 1 and 8, all cycles), and irinotecan 65 mg/m\^2 (days 1 and 8, all cycles). Thoracic Radiotherapy (TRT) was administered at 1.8 Gy in 28 daily fractions to a total dose of 50.4 Gy, beginning on day 1 of cycle 3.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
21
Other Number Affected:
21
Other Number At Risk:
21
Study:
NCT00109850
Results Section:
NCT00109850
Adverse Events Module:
NCT00109850